Skip to content
healthcare.dev

Lacosamide

NDC 69315-318, Lacosamide, solution, from Leading Pharma, LLC.

Product NDC
69315-318
Status
Listed
Labeler
Leading Pharma, LLC
Dosage form
SOLUTION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA216461
DEA schedule
CV
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69315-318 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LACOSAMIDE10 mg/mL

Pharmacologic classes

Decreased Central Nervous System Disorganized Electrical Activity [PE]

Package NDCNDC-11Package
69315-318-2069315031820200 mL in 1 BOTTLE, PLASTIC (69315-318-20)
69315-318-4669315031846465 mL in 1 BOTTLE, PLASTIC (69315-318-46)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/45786c84-51ef-4440-bc88-2501951e4c41
  • NADAC price for package 69315031820

    GET /v1/drugs/nadac/69315031820

Use it

Look up 69315-318 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69315-318 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69315-318. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.